Anti-neutrophil Cytoplasmic Antibody (c-ANCA) Positive Recurrent Eosinophilic Fasciitis Responsive to Cyclophosphamide

Haiduc, Virginia Florina; Erkan, Doruk; Kirou, Kyriakos A.; Birchansky, Sherri; Park, Josephine; Danon, Moris J.

doi:10.1007/s11420-007-9067-y

Cited by 10 publications

(3 citation statements)

References 19 publications

(28 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is substantial agreement among published cases and case series that corticosteroids are the first-line treatment for eosinophilic fasciitis and are usually effective in over 70% of cases. Other treatments include non-steroidal anti-inflammatory drugs, D-penicillamine, chloroquine, cimetidine, methotrexate, azathioprine, cyclosporine A, infliximab, UVA-1, and bath PUVA ( 10 , 11 ).…”

Section: Discussionmentioning

confidence: 99%

Eosinophilic Fasciitis: What Matters in Management in a Developing Country—A Case Report with Two and a Half-year Follow-up

Islam

Abdal

et al. 2012

J Health Popul Nutr

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Eosinophilic Fasciitis: What Matters in Management in a Developing Country—A Case Report with Two and a Half-year Follow-up

Islam

Abdal

et al. 2012

J Health Popul Nutr

View full text Add to dashboard Cite

show abstract

“…Other treatments include NSAIDs, D-penicillamine, chloroquine, cimetidine, methotrexate, azathioprine, cyclosporin A, infliximab, UVA-1, and bath PUVA [10,11]. …”

Section: Discussionmentioning

confidence: 99%

“…There is substantial agreement among published cases or case series that corticosteroids are the first-line treatment for EF and are usually effective in >70% of cases. Other treatments include NSAIDs, D-penicillamine, chloroquine, cimetidine, methotrexate, azathioprine, cyclosporin A, infliximab, UVA-1, and bath PUVA [ 10 , 11 ].…”

Section: Discussionmentioning

confidence: 99%

Unusual presentation of eosinophilic fasciitis: two case reports and a review of the literature

et al. 2010

View full text Add to dashboard Cite

IntroductionEosinophilic fasciitis is an uncommon disorder with unknown etiology and a poorly understood pathogenesis. We present the cases of two patients with eosinophilic fasciitis with unusual presentation, and describe the clinical characteristics and laboratory findings related to them.Case presentationThe first case involves a 29-year-old Turkish man admitted with pain, edema and induration of his right-upper and left-lower limbs. Unilateral edema and stiffness with prominent pretibial edema was noted upon physical examination. A high eosinophil count was found on the peripheral smear. The second case involves a 63-year-old Turkish man who had pain, edema, erythema, and itching on his upper and lower extremities, which developed after strenuous physical activity. He had cervical lymphadenopathy and polyarthritis upon physical examination, and rheumatoid factor and antinuclear antibody upon laboratory examination.ConclusionEosinophilic fasciitis can present with various symptoms. When patients exhibit eosinophilia, arthralgia and myalgia, eosinophilic fasciitis should be considered as a possible diagnosis.

show abstract

Eosinophilic fasciitis during pregnancy: case report and review of literature

et al. 2017

View full text Add to dashboard Cite

The authors describe the case of a 23-year-old woman who was referred to the rheumatologist due to symmetrical and progressive stiffness, induration, and swelling of arms and thighs at the 12th week of her first gestation. The characteristic clinical aspect of 'peau d'orange', associated to the histopathologic results of the deep biopsy of the skin confirmed the diagnosis of eosinophilic fasciitis. Treatment with oral prednisone, at an initial dose of 1 mg/kg/day, was effective and rapidly tapered to 10 mg/day till the birth of a healthy newborn. A literature review showed only one previous description of pregnancy and eosinophilic fasciitis.

show abstract

Anti-neutrophil Cytoplasmic Antibody (c-ANCA) Positive Recurrent Eosinophilic Fasciitis Responsive to Cyclophosphamide

Cited by 10 publications

References 19 publications

Eosinophilic Fasciitis: What Matters in Management in a Developing Country—A Case Report with Two and a Half-year Follow-up

Eosinophilic Fasciitis: What Matters in Management in a Developing Country—A Case Report with Two and a Half-year Follow-up

Unusual presentation of eosinophilic fasciitis: two case reports and a review of the literature

Eosinophilic fasciitis during pregnancy: case report and review of literature

Contact Info

Product

Resources

About